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Background:We hypothesized 1) that long-term ventricular outcome and exercise capacity would be better in
patients with isolated pulmonary valve stenosis (PS) treated with balloon pulmonary valvuloplasty (BPV)
than in patients operated for tetralogy of Fallot (TOF), and 2) that ventricular outcome and exercise capacity
would not be different in PS patients and healthy controls.
Methods: We included 21 PS patients after BPV (16.2±5.2 years) and 21 patients operated for TOF
(16.6±5.6 years), matching them for gender, age at treatment, and age at study. Patients underwent
cardiovascular magnetic resonance (CMR) imaging, exercise testing, 12-lead ECG and 24-hour Holter
monitoring for assessment of right ventricular (RV) size and function, pulmonary regurgitation (PR), exercise
capacity and electrocardiographic status. Healthy controls for CMR imaging and exercise testing were
matched for gender and age at study.
Results: RV volumes and PR percentage were signiﬁcantly larger in TOF patients than in PS patients;
biventricular ejection fraction (EF) was not different. PR wasmild in most PS patients. RV end-systolic volume
was signiﬁcantly larger in PS patients than in healthy controls; RVEF was signiﬁcantly lower. Both patient
groups had similar exercise test results. Peak workload and VO2 max. were signiﬁcantly lower in PS patients
than in healthy controls.
Conclusions: Longstanding mild PR in PS patients can lead to an enlarged RV, reduced RV function and reduced
exercise capacity. Despite more PR and larger RV volumes in TOF patients, exercise capacity and biventricular
function are similar in both patient groups.
© 2011 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
Residual pulmonary regurgitation (PR) often occurs after treat-
ment for congenital heart disease (CHD), particularly after repair of
tetralogy of Fallot (TOF) [1–4] and isolated pulmonary valve stenosis
(PS) [5–8]. The effects of severe PR on right ventricular (RV) function
and clinical outcome include RV dilatation, decreased right and left
ventricular (LV) function, reduction of exercise capacity, arrhythmias,
and increased risk of sudden cardiac death [1–3,9,10]. A pulmonary
valve replacement (PVR) is often considered in patients treated for
TOF, but the best time for performing a PVR is still uncertain,
especially in patients with asymptomatic PR [11–15].ren's Hospital, Department of
060, 3000 CB, Rotterdam, The
72.
lbing).
e Elsevier OA license.Before corrective treatment, the RV is subjected to pressure
overload in both types of CHD. In TOF patients, this is combined
with hypoxemia caused by a right-to-left shunt at the ventricular level
(ventricular septal defect (VSD)). Treatment options also differ
signiﬁcantly: TOF patients undergo a surgical repair in early
childhood, whereas patients with isolated PS are now treated with
percutaneous balloon pulmonary valvuloplasty (BPV) [16]. These
factors may add to differences in long-term outcome with respect to
RV function and clinical status.
Long-term outcome in patients after treatment for isolated PS has
been studied less extensively than in patients after repair of TOF and
most reports in PS patients focus primarily on results of residual
pulmonary valve (PV) peak gradients. Results at long-term follow-up
are excellent in the majority of the patients, although mild PR is often
reported. While most studies have used echocardiography in their
evaluation of long-term outcome in patients treated for isolated PS
[5–8], very few have used the current gold standard technique for
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(CMR) imaging [17].
This study was therefore based on two hypotheses: 1) we
hypothesized that long-term ventricular function, exercise capacity
and clinical status would be better in patients treated for isolated PS
than in patients treated for TOF. 2) We hypothesized that ventricular
function, exercise capacity and clinical status in PS patients would not
differ from those in healthy controls.
To test these hypotheses, we compared the long-term outcome in
PS patients after BPV with those in a matched group of TOF patients
and in a matched group of healthy controls.
2. Methods
2.1. Patients
The study population of the PS patients consisted of patients who underwent
balloon pulmonary valvuloplasty for isolated pulmonary valve stenosis at the Erasmus
Medical Center between 1990 and 1995. Thirty patients could be identiﬁed from the
medical records of the Departments of Pediatric Cardiology and Cardiothoracic Surgery;
21 agreed to participate in the current study. They underwent CMR imaging, exercise
testing, echocardiography, 12-lead electrocardiography (ECG), and 24-hour Holter
monitoring. These PS patients were compared to patients after repair of tetralogy of
Fallot. Patients with TOF undergo the aforementioned tests as part of routine clinical
care in our center. TOF patients were randomly selected from the clinical database and
were matched to the PS patients for gender, age at treatment, and age at study. Medical
records were reviewed for patient characteristics.
Healthy controls, who were matched for gender and age at study, were randomly
selected from our databases of healthy volunteers, who had participated in a study to
obtain normal values of biventricular function with CMR imaging or in a study to obtain
normal values of exercise capacity. Since not all healthy controls had undergone both
tests, 2 separate control groups were composed: one for results of CMR imaging and the
other for results of exercise testing.
The research study was approved by the local Ethical Committee; all patients, and if
required, their parents, gave informed consent.
2.2. Echocardiography
Conventional echocardiography was carried out, consisting of transthoracic M-
mode and two-dimensional echocardiography, as well as pulsed-wave and continuous-
wave Doppler measurements, using an ultrasound Philips Sonos 5500 (Philips Medical
Systems, Best, the Netherlands). The maximum peak gradient across the PV was
determined using Doppler measurements and calculated using the modiﬁed Bernoulli
equation (ΔP=4∗(Vmax.2)). PR was semiquantitatively classiﬁed as none, mild,
moderate or severe, according to the length, the width and the localization of the
regurgitant ﬂow [18].
2.3. CMR image acquisition
CMR imaging was performed using a 1.5 Tesla system (General Electric, Milwaukee,
WI, USA) and an 8-channel phased-array cardiac surface coil. Standard localizer
imaging planes were acquired to plan a short axis set and ﬂow measurements of the
pulmonary valve. The short axis set, using steady-state free precession cine imaging,
was acquired from base to apex. Typical imaging parameters were: repetition time
3.5 msec., echo time 1.5 msec., ﬂip angle 45°, slice thickness 8–9 mm., inter-slice gap 0–
1 mm., ﬁeld of view 320×240 mm., and matrix 160×128 mm. Flow measurements
were performed perpendicular to ﬂow. Typical imaging parameters were: repetition
time 4.8 ms., echo time 2.6 ms., ﬂip angle 18°, slice thickness 7 mm., inter-slice gap
0 mm., ﬁeld of view 290×220 mm, and matrix 256×128 mm. Velocity encoding was
set at 150 cm/s. and was increased whenever phase aliasing occurred. All images were
obtained during breath-hold in end-expiration.
2.4. CMR analysis
Analysis was performed on a commercially available Advanced Windows
workstation (General Electric Medical Systems), equipped with the software packages
QMASS (version 5.2) and QFLOW (version 3.2) (Medis Medical Imaging Systems,
Leiden, the Netherlands).
The ventricular volumetric data set was quantitatively analyzed using manual
outlining of endocardial and epicardial borders in end-systole and end-diastole.
Papillary muscles and trabeculations were included in the ventricular cavity. The
interventricular septumwas included in the left ventricular mass. Ventricular mass was
calculated as the difference between the epicardial and endocardial contours
multiplied by the slice thickness and a speciﬁc gravity of the myocardium of 1.05 g/
ml [19].
The following parameters were calculated: biventricular end-diastolic volume
(EDV), end-systolic volume (ESV), stroke volume (SV), ejection fraction (EF), andmass.
Pulmonary regurgitation (in milliliters) was normalized for systolic SV in the mainpulmonary artery and was expressed as a percentage. Additionally, RV effective stroke
volume (eff.SV) was calculated to correct for PR: RVeff.SV=RVSV−PR volume. Results
were indexed for body surface area (BSA). Tominimize observer variability, all data sets
were analyzed by the same observer (SEL).
2.5. Exercise test
Patients performed a maximal bicycle exercise test on a Jaëger Oxycom Champion
System (Viasys Healthcare, Hoechberg, Germany). Workload was increased by 15–
20 W per minute. Patients were encouraged to perform until exhaustion. Tests were
regarded as maximal when the respiratory quotient (RQ) at peak exercise was ≥1.05.
The following parameters were recorded: peak heart rate, peak workload, peak oxygen
uptake (VO2 max.), anaerobic threshold (AT), and the ventilatory response to carbon
dioxide production (VE/VCO2). The AT was determined using the V-slope method [20].
The VE/VCO2 slope was obtained by linear regression analysis of the data acquired
throughout the entire period of exercise.
2.6. Electrocardiography
A standardized 12-lead ECG was obtained to determine rhythm status, QRS duration
and QT interval corrected for heart rate. A 24-hour Holter monitoring was performed in
patients on a day with usual activities.
2.7. Statistical analysis
Data are expressed as mean (±standard deviation), as median (range) or as counts
(percentages). Differences in continuous data between groups of patients were
evaluated using the Student t-test, paired t-test or with nonparametric tests.
Differences in categorical data between groups of patients were evaluated with the
chi-square or Fisher exact test.
Analysis was performed using the SPSS statistical software package version 15.0
(SPSS, Inc., Chicage, Ill, USA). A p-value b0.05 was considered to indicate statistical
signiﬁcance.
3. Results
The patient characteristics are displayed in Table 1. There were no
signiﬁcant differences in height, weight, and BSA between the 2
patient groups, who were matched for gender, age at treatment and
age at study. NYHA class was not signiﬁcantly different between the
PS and TOF patients.
In 7 TOF patients, a palliative shunt had been placed before
corrective surgery (33%); 14 TOF patients had corrective surgery with
the use of a transannular patch (70%). In 4 patients with TOF,
additional surgery had been performed after the initial surgery and
before participation in the study. This included closure of a residual
VSD in 3 patients and additional relief of pulmonary stenosis in all 4.
Three patients with isolated PS had undergone a re-intervention after
BPV and before participation in the study. One PS patient ﬁrst
underwent a repeat BPV, but eventually a surgical relief of the repeat
pulmonary stenosis was needed twice. One other PS patient
underwent closure of a persistent ductus arteriosus; another had
surgical repair of moderate tricuspid regurgitation.
The pulmonary valve peak gradient before treatment was signif-
icantly higher in PS patients than in TOF patients (83±21 mm Hg
(PS patients) vs. 63±20 mm Hg (TOF patients), p=0.004) (Table 1).
The PV peak gradient signiﬁcantly decreased immediately after
treatment in both patient groups, and decreased even further at
long-term follow-up in PS patients. The PV peak gradient immediately
after treatmentwas not signiﬁcantly different between PS patients and
TOF patients. Even so, the PVpeak gradient at long-term follow-upwas
not signiﬁcantly different between the patient groups.
At long-term follow-up, 20 PS patients (95%) and all TOF patients
had pulmonary regurgitation; this was predominantly classiﬁed as
mild or moderate in PS patients, and as moderate or severe in TOF
patients.
3.1. CMR imaging
PR percentage was signiﬁcantly higher in TOF patients than in PS
patients (PR: 30±13% (TOF patients) vs. 10±10% (PS patients),
Table 1
Characteristics of the study population and results of echocardiography.
Characteristic PS patients
(N=21)
TOF patients
(N=21)
Male 9 (43%) 9 (43%)
Height (cm) 165 (± 13) 159 (± 13)
Weight (kg) 58 (± 20) 53 (± 14)
BSA (m2) 1.62 (± 0.33) 1.53 (0.25)
NYHA Class
Class I 20 (95%) 16 (76%)
Class II 1 (5%) 5 (24%)
Age at treatment (yrs) 3.6 (± 4.2) 3.0 (± 3.2)
Age at study (yrs) 16.2 (± 5.2) 16.6 (± 5.6)
Interval between treatment and
study (yrs)
12.6 (± 2.1) 13.7 (± 3.1)
Echocardiography
PV peak gradient before
treatment (mmHg)
83 (± 21)* 63 (± 20)
PV peak gradient immediately
after treatment (mmHg)
26 (± 10)† 26 (± 15)†
PV peak gradient at long-term
follow-up (mmHg)
15 (± 11)‡ 20 (± 9)
Reported data are expressed as mean (SD) or as counts (percentages).
* Signiﬁcant difference between PS patients and TOF patients.
† Signiﬁcant difference between results before treatment and immediately after
treatment.
‡ Signiﬁcant difference between results immediately after treatment and at long-term
follow-up.
Abbreviations: PS=pulmonary stenosis; TOF=tetralogy of Fallot; BSA=body surface
area; NYHA=New York Heart Association; PV=pulmonary valve.
Table 2
Results of CMR imaging.
Parameter PS patients
(N=19)
TOF patients
(N=21)
Healthy controls
(N=21)
Age (yrs) 16.2 (± 5.2) 16.6 (± 5.6) 16.5 (± 5.0)
BSA (m2) 1.62 (± 0.33) 1.53 (0.25) 1.62 (± 0.23)
PR (%) 10 (± 10)* 30 (± 13) N/A
Right Ventricle
EDV (ml/m2) 101 (± 20)* 131 (± 29) 90 (± 18)
ESV (ml/m2) 51 (± 15)*† 66 (± 20) 41 (± 9)
SV (ml/m2) 50 (± 7)* 65 (± 12) 49 (± 11)
eff.SV (ml/m2) 45 (± 6) 45 (± 6) 49 (± 10)
EF (%) 50 (± 6)† 50 (± 6) 54 (± 3)
Mass (g/m2) 17 (± 4)* 22 (± 5) 17 (± 3)
Left ventricle
EDV (ml/m2) 81 (± 11) 85 (± 14) 85 (± 14)
ESV (ml/m2) 36 (± 7) 38 (± 10) 36 (± 6)
SV (ml/m2) 45 (± 6) 47 (± 7) 49 (± 11)
EF (%) 55 (± 4) 55 (± 5) 57 (± 5)
Mass (g/m2) 53 (± 11) 52 (± 10) 50 (± 11)
Reported data are expressed as mean (SD).
* Signiﬁcant difference between PS patients and TOF patients.
† Signiﬁcant difference between PS patients and healthy controls.
Abbreviations: CMR=cardiovascular magnetic resonance; PR=pulmonary
regurgitation; EDV=end-diastolic volume; ESV=end-systolic volume; SV=stroke
volume; eff.SV = effective stroke volume; EF=ejection fraction; N/A=not applicable.
Other abbreviations as in Table 1.
Table 3
Results of exercise testing.
Parameter PS patients
(N=19)
TOF patients
(N=19)
Healthy controls
(N=21)
Age (years) 16.2 (± 5.2) 16.6 (± 5.6) 16.2 (± 4.1)
Height (cm) 165 (± 13) 159 (± 13) 166 (± 15)
Peak heart rate (beats/min) 176 (± 15)* 181 (± 12) 185 (± 8)
Peak workload (Watt) 142 (± 40)* 138 (± 34) 186 (± 44)
(N=19) (N=15) (N=21)
RQ at peak exercise 1.17 (± 0.07) 1.15 (± 0.06) 1.17 (± 0.07)
VO2 max. (ml/kg/min) 36 (± 10)* 38 (± 7) 44 (± 7)
AT (ml/kg/min) 26 (± 8)* 27 (± 6) 32 (± 6)
VE/VCO2 slope 29 (± 5) 30 (± 5) 28 (± 5)
Reported data are expressed as mean (SD).
* Signiﬁcant difference between PS patients and healthy controls.
Abbreviations: RQ=respiratory quotient; VO2 max.=peak oxygen uptake;
AT=anaerobic threshold; VE/VCO2 slope=ventilatory response to carbon dioxide
production. Other abbreviations as in Table 1.
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and mass were also signiﬁcantly larger in TOF patients than in PS
patients (RVEDV: 131±29ml/m2 (TOF patients) vs. 101±20 ml/m2
(PS patients), p=0.001; RVESV: 66±20 ml/m2 (TOF patients)
vs. 51±15 ml/m2 (PS patients), p=0.009). RV effective SV,
biventricular EF and LV volumes and mass were not signiﬁcantly
different between the 2 patient groups.
RVESV was signiﬁcantly larger in PS patients than in healthy
controls, and RVEFwas signiﬁcantly lower (RVESV: 51±15 ml/m2 (PS
patients) vs. 41±9 ml/m2 (healthy controls), p=0.02; RVEF: 50±6%
(PS patients) vs. 54±3% (healthy controls), p=0.02). RVEDV was
larger in PS patients than in healthy controls, but this was not
statistically signiﬁcant (RVEDV: 101±20 ml/m2 (PS patients) vs.
90±18 ml/m2 (healthy controls), p=0.09). All other parameters
were not signiﬁcantly different between PS patients and healthy
controls.
3.2. Exercise test
The exercise test results are given in Table 3. None of the
parameters was signiﬁcantly different between PS patients and TOF
patients. Peak heart rate, peak workload, VO2 max., and the AT were
signiﬁcantly lower in PS patients than in healthy controls (VO2 max.:
36±10 ml/kg/min (PS patients) vs. 44±7 ml/kg/min (healthy con-
trols), p=0.004). The VE/VCO2 slope was not signiﬁcantly different
between PS patients and healthy controls.
3.3. Electrocardiography
12-lead ECG data were available for all patients. All patients were
in sinus rhythm. The QRS duration was signiﬁcantly longer in TOF
patients than in PS patients (127±23 ms. (TOF patients) vs. 95±
20 ms. (PS patients), pb0.001). A complete right-bundle branch block
(RBBB) was signiﬁcantly more present in TOF patients than in PS
patients (a complete RBBB in 15 TOF patients (71%) vs. 1 PS patient
(5%), pb0.001). The heart rate, PQ time, and QT time corrected for
heart rate were not signiﬁcantly different.Results of 24-hourHolter recordingswere available for all PS patients
and 11 TOF patients. There were no signiﬁcant differences in mean,
minimal or maximal heart rate, and total supraventricular premature
beats. The median number of total ventricular premature beats (VPB)
was higher in TOF patients than in PS patients, although this was not
statistically signiﬁcant (number of VPBs: 2 (0–7341) (TOF patients) vs. 1
(0–890) (PS patients), p=0.07). One PS patient had 1 run of ventricular
tachycardia (VT), consisting of 5 heart beats. Another PS patient had 2
runs of supraventricular tachycardia (SVT), consisting of 13 heart beats
in total. None of the TOF patients showed runs of VT or SVT.
4. Discussion
Our results show that adolescent patients with isolated pulmonary
valve stenosis and tetralogy of Fallot, whose age at treatment,
duration of follow-up, and residual RV outﬂow gradient were similar,
have similar clinical outcomes (NYHA class, and exercise perfor-
mance). Although clinical condition, as assessed using the NYHA class,
was good in the majority of the patients, exercise performance was
signiﬁcantly reduced in both patient groups. Residual PR in the PS
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13% in the TOF group. Considering the differences in techniques used
to relieve the RV outﬂow stenosis, it was not unexpected to ﬁnd more
PR after treatment for TOF than for isolated PS. Although RV volumes
were signiﬁcantly larger in TOF patients than in PS patients, LV size,
RV effective SV, and biventricular function were not signiﬁcantly
different. Despite the minimal residual RV outﬂow stenosis and mild
PR in the PS group, CMR imaging revealed a larger RVESV and a lower
RVEF in the PS group compared with the results in healthy controls.
Relatively few studies have reported on the long-term clinical
outcome after BPV for isolated PS. Our study conﬁrms that PR is
generally mild in PS patients at follow-up after BPV [5–8]: only 3 PS
patients in our study had a PR percentage N20%. RV enlargement has
been considered uncommon in PS patients after BPV. Assessment of
RV dimensions in most previous studies, however, has been done
using echocardiography [5,7,21]. Recently, Harrild et al. studied PS
patients after BPV using CMR imaging and reported that mild PR and
mild RV dilatationwere often present at long-term follow-up, but that
severe PR and severe RV dilatation were very uncommon [17]. Our
own results demonstrated that longstanding mild PR in PS patients is
associated with an increase in RVESV and a decrease in global RV
function. Furthermore, our PS patients had a reduced exercise
capacity. These results conﬁrm those of the study by Harrild et al.,
who also found a reduced VO2 max. in PS patients.
Although results of exercise testing in patients after repair of TOF
are available in the literature, their results differ considerably
[10,11,22]. In adults operated on for TOF, VO2 max. has varied
between 58% and 80% of predicted values [10,22]. Age at operation
and duration of follow-up are important factors to consider. The good
results in our TOF groupmight be explained by our patients' relatively
young age at surgery and young age at study relative to those of the
TOF patients described in earlier studies. A younger age at surgery has
been recognized to be related to amore favorable clinical outcome [3].
In contrast with our second hypothesis, exercise performance in PS
patients was signiﬁcantly lower than in healthy controls. This might in
part be explained by impaired chronotrophy, since the maximal heart
ratewas signiﬁcantly lower than inhealthy controls. It is striking that the
TOF patients in our study had similar results on exercise testing as PS
patients, despite signiﬁcantly higher amounts of PR. A similar result was
also found in a studybyYetmanet al.,who compared agroupof pediatric
PS patients after surgical valvulotomy with a matched group of TOF
patients [23]. Remarkably, exercise capacitywasmore severely impaired
in the PS patients in Yetman's study than it was in the TOF patients. The
authors argued that thismight result from diastolic RV restriction in TOF
patients, which was suggested to improve exercise capacity, as reported
by Gatzoulis et al. [24]. This has however, not been conﬁrmed either in
pediatric and adolescent TOF patients who were operated on at a
younger age or in a recent study in adult TOF patients [22,25].
In recent years, an abnormal ventilatory response to exercise, as
assessed by an elevated VE/VCO2 slope, has been shown to be a
powerful predictor of cardiac-related mortality in patients with CHD
[10,26]. Our results were comparable to the results reported by
Giardini et al., who found a VE/VCO2 slope of 31±5 in their total
group of TOF patients [10]. In our study however, the VE/VCO2 slope
was not signiﬁcantly different between PS patients and healthy
controls and was also not different between the 2 patient groups.
Our study conﬁrms the adverse effects of longstanding PR. At the
same time, exercise performance and ventricular function were
comparable between the PS and TOF group, despite important
differences in RV dimensions. Based on the fact that exercise capacity
was similar inbothpatient groups, the relatively short hypoxemic period
before corrective surgery doesn't seem to have a negative inﬂuence on
exercise capacity in these TOF patients at the current follow-upduration.
It seems therefore that other factors have more impact on exercise
capacity, like for example the amount of PR or global RV function. PR
percentage was not correlatedwith peak oxygen uptake or the VE/VCO2slope however, although the limited number of patients in the study is a
factor to consider. The similar biventricular function in our PS and TOF
patients might be an explanation for their similar exercise test results.
A recent functional analysis of 3 components of the RV in
adolescent TOF patients by Bodhey et al., demonstrated that the
ejection fraction of the apical trabecular component, which provides
the major ejectile momentum, is maintained in patients with slight to
moderate ventricular dysfunction [27]. In TOF patients operated on at
a young age, RV contractile reserve is also well preserved [28]. These
ﬁndings suggest that RV myocardial performance may be well
maintained in TOF patients operated on at a young age, despite
enlarged RV size. The RV may therefore be well suited to perform its
role of maintaining LV preload in this situation.
It might be speculated that long-term prognosis in TOF patients
eventually will be worse than in PS patients, since TOF patients
already have a more severe RV dilatation at this follow-up duration.
Previous studies have suggested that there is a threshold for the
dimension of the RVEDV, above which the RV does not recover
completely, even if a PVR is performed [11,12,14,15].
Arrhythmias are an important problem in patients with residual
PR, particularly in patients with TOF [9,29]. Signiﬁcant ventricular
arrhythmias in PS patients are uncommon [30], which is in agreement
with our results. A QRS duration ofN180 ms and an older age at repair
are associated with a higher risk of ventricular tachycardia and
sudden death [9]. Dietl et al. reported a signiﬁcant reduction in
ventricular arrhythmias in TOF patients who had had a transatrial
repair than in those who had had a transventricular repair [29].
Signiﬁcant ventricular arrhythmias in our TOF patients were uncom-
mon. This relates to the mild QRS prolongation, young age at repair
and transatrial surgical repair in most of the patients. None of our
patients had a QRS duration N180 msec.
5. Limitations
No echocardiographic data was available for 10 TOF patients
before treatment and for 2 TOF patients immediately after treatment,
in all of whom the assessment of RV outﬂow gradients had been based
on results from cardiac catheterizations. Particularly, the signiﬁcant
difference in PV peak gradient before treatment between PS patients
and TOF patients should therefore be interpreted with caution.
In some of the older TOF patients, data from exercise testing and
24-hour Holter monitoring were missing. Since exercise capacity
might be better preserved at a younger age, this may have resulted in
an overestimation of the exercise capacity in the TOF patients.
We studied children, adolescents and young adults treated at a
young age. Our results are therefore representative for patients with a
similar age and follow-up-duration.
Since we only had small patient groups, a limited statistical power
is a factor to consider.
6. Future perspectives
Assessment of RV volumes and function with CMR imaging in
patients treated with BPV for isolated PS has hardly been done before.
We found that PS patients had a larger RV, a lower RV function, and a
lower exercise capacity than healthy controls, although their clinical
condition was excellent. Since we only had a small PS patient group,
results should be conﬁrmed in larger studies. Serial follow-up studies
in PS patients are necessary to evaluate the degree of progression of
their PR and RV dilatation and to see how this inﬂuences their clinical
condition and exercise capacity later in life.
Serial follow-up data might also be useful to evaluate whether
certain parameters, like PR percentage and RV dilatation, might be
more progressive in the TOF group and to see how this would then
inﬂuence biventricular function and exercise capacity at longer term
follow-up.
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In contrast to our hypothesis, pediatric and adolescent patients
with isolated pulmonary valve stenosis have a lower exercise
capacity, a larger right ventricle and a lower RV function than healthy
controls, although their clinical condition is excellent. However,
exercise performance and biventricular function are similar to those
in patients with tetralogy of Fallot, despite more severe pulmonary
regurgitation and larger RV volumes in Fallot patients.
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